• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Med . Revealing COVID-19 Transmission in Australia by SARS-CoV-2 Genome Sequencing and Agent-Based Modeling

tetano

Editor, Senior Moderator
Nat Med


. 2020 Jul 9.
doi: 10.1038/s41591-020-1000-7. Online ahead of print.
Revealing COVID-19 Transmission in Australia by SARS-CoV-2 Genome Sequencing and Agent-Based Modeling


Rebecca J Rockett[SUP] 1 2 [/SUP], Alicia Arnott[SUP] 1 2 3 [/SUP], Connie Lam[SUP] 1 2 [/SUP], Rosemarie Sadsad[SUP] 1 2 4 [/SUP], Verlaine Timms[SUP] 1 2 [/SUP], Karen-Ann Gray[SUP] 1 2 [/SUP], John-Sebastian Eden[SUP] 1 5 [/SUP], Sheryl Chang[SUP] 6 [/SUP], Mailie Gall[SUP] 3 [/SUP], Jenny Draper[SUP] 3 [/SUP], Eby M Sim[SUP] 2 3 [/SUP], Nathan L Bachmann[SUP] 2 3 [/SUP], Ian Carter[SUP] 3 [/SUP], Kerri Basile[SUP] 3 [/SUP], Roy Byun[SUP] 7 [/SUP], Matthew V O'Sullivan[SUP] 1 2 3 [/SUP], Sharon C-A Chen[SUP] 1 2 3 [/SUP], Susan Maddocks[SUP] 3 [/SUP], Tania C Sorrell[SUP] 1 2 8 [/SUP], Dominic E Dwyer[SUP] 1 2 3 [/SUP], Edward C Holmes[SUP] 1 9 [/SUP], Jen Kok[SUP] 1 2 3 [/SUP], Mikhail Prokopenko[SUP] 1 6 [/SUP], Vitali Sintchenko[SUP] 10 11 12 13 [/SUP]



Affiliations

Abstract

In January 2020, a novel betacoronavirus (family Coronaviridae), named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified as the etiological agent of a cluster of pneumonia cases occurring in Wuhan City, Hubei Province, China[SUP]1,2[/SUP]. The disease arising from SARS-CoV-2 infection, coronavirus disease 2019 (COVID-19), subsequently spread rapidly causing a worldwide pandemic. Here we examine the added value of near real-time genome sequencing of SARS-CoV-2 in a subpopulation of infected patients during the first 10 weeks of COVID-19 containment in Australia and compare findings from genomic surveillance with predictions of a computational agent-based model (ABM). Using the Australian census data, the ABM generates over 24 million software agents representing the population of Australia, each with demographic attributes of an anonymous individual. It then simulates transmission of the disease over time, spreading from specific infection sources, using contact rates of individuals within different social contexts. We report that the prospective sequencing of SARS-CoV-2 clarified the probable source of infection in cases where epidemiological links could not be determined, significantly decreased the proportion of COVID-19 cases with contentious links, documented genomically similar cases associated with concurrent transmission in several institutions and identified previously unsuspected links. Only a quarter of sequenced cases appeared to be locally acquired and were concordant with predictions from the ABM. These high-resolution genomic data are crucial to track cases with locally acquired COVID-19 and for timely recognition of independent importations once border restrictions are lifted and trade and travel resume.
 
Back
Top Bottom